Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property

被引:71
作者
Yue, Peng-Fei [1 ,2 ]
Li, Yu [1 ]
Wan, Jing [1 ]
Yang, Ming [1 ]
Zhu, Wei-Feng [1 ]
Wang, Chang-Hong [2 ]
机构
[1] Jiangxi Univ Tradit Chinese Med, Minist Educ, Key Lab Modern Preparat TCM, Nanchang, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China
关键词
Solid nanosuspension; Formability; Nanodispersion; Solidification; Contact angle; Cohesive energy; Redispersibility; DRUG NANOSUSPENSIONS; FORMULATION; DELIVERY; STABILIZATION; NANOCRYSTALS; ALBENDAZOLE; SUSPENSIONS; PROGRESS;
D O I
10.1016/j.ijpharm.2013.06.050
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Few or no attempts have been made so far to understand the feasibility of solid nanosuspension formulation during nanodispersion and solidification in terms of drug properties and stabilizer characterizations. In order to establish a knowledge base about the effect of physicochemical property of drug compounds and stabilizers on solid nanosuspension production during nanodispersion and solidification, a comparative study was firstly performed on 10 different stabilizers at 3 concentrations for 8 structurally different drug compounds. Synthetic polymers (HPMC, PVP K30, CMS-Na and MC) displayed a poor stabilizing performance (10% success rate on average) during nanodispersion, but polymers showed better potential when higher concentrations was applied during freezing and lyophilization. Meanwhile, an effect for the surfactants group was even more pronounced during nanodispersion. However, the solid nanosuspension stabilized by surfactants showed the worst formability potential when be applied in setted concentrations during freezing and lyophilization. From the point of view of drug property, it was found that the surface hydrophobicity and cohesive energy of drug, were responsible for the formability of the solid nanosuspension during nanodispersion and solidification. Wetting index (k) and Delta E were concluded to have a direct correlation on the feasibility of formation of a stable solid nanosuspension, which can give a formulation design strategy from where candidate drugs and stabilizers with a set of properties. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 24 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]  
Beirowski J., 2009, P PAR DRUG ASS FRANK
[3]  
Beirowski J., 2010, P 7 WORLD M PHARM MA
[4]   Freeze Drying of Nanosuspensions, 2: the Role of the Critical Formulation Temperature on Stability of Drug Nanosuspensions and Its Practical Implication on Process Design [J].
Beirowski, Jakob ;
Inghelbrecht, Sabine ;
Arien, Albertina ;
Gieseler, Henning .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (10) :4471-4481
[5]   Freeze-Drying of Nanosuspensions, 1: Freezing Rate Versus Formulation Design as Critical Factors to Preserve the Original Particle Size Distribution [J].
Beirowski, Jakob ;
Inghelbrecht, Sabine ;
Arien, Albertina ;
Gieseler, Henning .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (05) :1958-1968
[6]   1,3-Dicyclohexyl urea nanosuspension for intravenous steady-state delivery in rats [J].
Chiang, Po-Chang ;
Wahlstrom, Jan L. ;
Selbo, Jon G. ;
Zhou, Shuxia ;
Wene, Steve P. ;
Albin, Lesley A. ;
Warren, Chad J. ;
Smith, Mark E. ;
Roberds, Steven L. ;
Ghosh, Sarbani ;
Zhang, L. Lena ;
Pretzer, Denise K. .
JOURNAL OF EXPERIMENTAL NANOSCIENCE, 2007, 2 (03) :239-250
[7]   Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system [J].
Gao, Lei ;
Zhang, Dianrui ;
Chen, Minghui .
JOURNAL OF NANOPARTICLE RESEARCH, 2008, 10 (05) :845-862
[8]   Nanosizing - Oral formulation development and biopharmaceutical evaluation [J].
Kesisoglou, Filippos ;
Panmai, Santipharp ;
Wu, Yunhui .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :631-644
[9]  
Kumar MP, 2008, CURR NANOSCI, V4, P53
[10]  
Kumar MP, 2007, CURR NANOSCI, V3, P191